@ToxGenSolutions BV disembarks on its data-driven journey towards novel tools and treatments for improving the quality of life of patients with sporadic #Alzheimers.
February 09, 2018
@TozGenSolutions and its partners in the project #Herinneringen (''Memories'') have disembarked on their journey towards a technology platform for 1) development of a non-invasive method for early #diagnosis, 2) identification of novel #drug targets and 3) improved #drugdevelopment approaches.
The building of the platform is data-driven (as opposed to the current hypothesis-driven strategies) and based on adverse outcome pathways (#AOP) identified using #nonanimal genomics-based methods and involving cell models, and matched human clinical samples and human cohorts.
The overall objective is to break the current deadlock and to provide patients with sporadic #Alzheimers with novel tools and treatments that improve their quality of life.
Every partner in the consortium (icometrix, Katholieke Universiteit Leuven, reMYND, ToxGenSolutions, Universiteit Antwerpen, Universiteit Maastricht) is based in Flanders and the Southern Netherlands and is a leader in their professional field. Bundling these strengths and the resulting synergy will serve as a great stimulus for targeted innovation.
The total budget for “Memories” is €2,476,613.03. The project will run from January 1, 2018 up to and including December 31, 2020. The budget is provided by public organizations, such as Interreg. Vlaanderen-Nederland, the Dutch Ministry of Economic Affaires, the Flemish Region and Provinces.